Ticker > Company >

Shree Ganesh Remed. share price

Shree Ganesh Remedies Ltd.

BSE: 540737 SECTOR: Pharmaceuticals & Drugs  27k   163   10

700.00
-56.50 (-7.47%)
BSE: 13 Nov 04:01 PM

Price Summary

Today's High

₹ 759.9

Today's Low

₹ 670

52 Week High

₹ 950.05

52 Week Low

₹ 557.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

898.63 Cr.

Enterprise Value

918.75 Cr.

No. of Shares

1.28 Cr.

P/E

31.57

P/B

6.75

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  103.72

CASH

16.19 Cr.

DEBT

36.31 Cr.

Promoter Holding

70.5 %

EPS (TTM)

₹  22.17

Sales Growth

37.81%

ROE

26.87 %

ROCE

27.83%

Profit Growth

85.17 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year37.81%
3 Year36.89%
5 Year28.95%

Profit Growth

1 Year85.17%
3 Year42.32%
5 Year35.15%

ROE%

1 Year26.87%
3 Year23.77%
5 Year23.57%

ROCE %

1 Year27.83%
3 Year27.59%
5 Year28.58%

Debt/Equity

0.2974

Price to Cash Flow

29.51

Interest Cover Ratio

64.8828

CFO/PAT (5 Yr. Avg.)

0.895795640586021

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 70.50 0.00
Jun 2024 69.33 0.00
Mar 2024 69.33 0.00
Dec 2023 69.33 0.00
Sep 2023 69.33 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 42.318943879652% for the Past 3 years.
  • The company has shown a good revenue growth of 36.8922529016361% for the Past 3 years.
  • Company has been maintaining healthy ROE of 23.7657% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.588% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 64.8828.
  • The Company has been maintaining an effective average operating margins of 25.8767211155309% in the last 5 years.
  • Company’s PEG ratio is 0.392805772600011.
  • The company has an efficient Cash Conversion Cycle of 54.2297 days.
  • Company has a healthy liquidity position with current ratio of 2.982.
  • The company has a high promoter holding of 70.5%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 33.42 27.97 37.33 24.78 32.33
Total Expenditure 24.19 19.77 20.4 16.66 21.02
Operating Profit 9.23 8.21 16.93 8.12 11.31
Other Income 0.81 1.11 1.32 0.55 0.19
Interest 0.01 0.02 0.15 0.32 0.43
Depreciation 1.41 1.88 1.86 2.02 2.42
Exceptional Items 0 0 0 0 0
Profit Before Tax 8.61 7.42 16.25 6.34 8.65
Tax 2.05 2.62 3.66 1.68 2.23
Profit After Tax 6.56 4.8 12.59 4.65 6.42
Adjusted EPS (Rs) 5.33 3.84 10.01 3.62 5

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 58.43 49.08 71.29 91.36 125.9
Total Expenditure 47.48 35.43 53.37 67.92 84.08
Operating Profit 10.95 13.65 17.92 23.44 41.81
Other Income 4.18 2.09 3.57 0.72 3.07
Interest 0.14 0.07 0.15 0.18 0.6
Depreciation 2.24 2.73 3.34 3.74 6.11
Exceptional Items 0 0 0 0 0
Profit Before Tax 12.74 12.95 18.01 20.24 38.17
Tax 3.12 3.2 4.61 5.05 10.05
Net Profit 9.62 9.75 13.4 15.18 28.12
Adjusted EPS (Rs.) 7.96 8.07 11.08 12.14 21.89

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.97 10.01 12.01 12.51 12.84
Total Reserves 33.12 40 49.57 74.69 109.26
Borrowings 0.04 0 0 30.44 29.12
Other N/C liabilities 0.45 0.41 0.4 0.14 1.04
Current liabilities 9.67 10.19 15.04 25.15 25.96
Total Liabilities 52.26 60.6 77.02 142.92 178.22
Assets
Net Block 16.27 18.85 27.19 58.03 80.55
Capital WIP 0 2.05 3.09 15.16 16.63
Intangible WIP 0 0 0 0.24 0.29
Investments 0.05 0.07 0.08 0.08 0.16
Loans & Advances 0.93 0.6 0.61 2.15 3.18
Other N/C Assets 0.2 1.03 1.13 1.03 0.01
Current Assets 34.82 37.99 44.91 66.23 77.4
Total Assets 52.26 60.6 77.02 142.92 178.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 12.74 12.95 18.01 20.24 38.17
Adjustment -5.56 -7.84 -2.49 6.48 5.88
Changes in Assets & Liabilities -3.31 -1.8 1.91 -3.72 -5.47
Tax Paid 0 0 -4.01 -5.9 -8.14
Operating Cash Flow 3.88 3.31 13.42 17.1 30.45
Investing Cash Flow -2.91 -0.94 -11.91 -50.98 -33.18
Financing Cash Flow -0.21 -0.66 -1.09 38.66 9.85
Net Cash Flow 0.76 1.71 0.42 4.77 7.12

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 69.33 69.33 69.33 69.33 70.50
chandulal manubhai kothia... 48.72 48.72 48.72 48.72 48.72
gunjan chandulal kothia 3.20 3.20 3.20 3.20 3.20
hanshaben chandubhai koth... 11.42 11.42 11.42 11.42 11.42
kothia ashokkumar manubha... 0.08 0.08 0.08 0.08 0.08
manubhai jivabhai kothiya... 0.68 0.68 0.68 0.68 1.84
parth chandulal kothia 0.44 0.44 0.44 0.44 0.44
pooja gunjan kothia 4.79 4.79 4.79 4.79 4.79
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 30.67 30.67 30.67 30.67 29.50
babubhai k kotadiya 1.66 1.66 1.66 1.66 1.66
gunjan jayantibhai dhoraj... 1.71 1.71 1.71 1.71 1.71
v naga raja naidu - - 1.04 1.12 1.23
hansaben arvindbhai vasoy... 1.88 1.88 1.88 1.88 -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Shree Ganesh Remedies informs about press release 31 Oct, 3:10 PM Shree Ganesh Remed. - Quaterly Results 29 Oct, 6:41 PM Shree Ganesh Remed. - Quaterly Results 29 Oct, 6:41 PM Shree Ganesh Remedies informs about analyst meet 26 Sep, 5:17 PM Shree Ganesh Remed. - Quaterly Results 12 Aug, 7:05 PM Shree Ganesh Remed. - Quaterly Results 12 Aug, 7:05 PM Shree Ganesh Remedies informs about newspaper advertisement 3 Jun, 5:34 PM Shree Ganesh Remedies informs about outcome of board meeting 1 Jun, 3:35 PM Shree Ganesh Remed. - Quaterly Results 1 Jun, 2:10 PM Shree Ganesh Remed. - Quaterly Results 1 Jun, 2:10 PM Shree Ganesh Remed. - Quaterly Results 1 Jun, 2:10 PM Shree Ganesh Remed. - Quaterly Results 12 Feb, 10:48 PM Shree Ganesh Remed. - Quaterly Results 12 Feb, 10:48 PM Shree Ganesh Remedies informs about newspaper publication 13 Nov, 1:02 PM Shree Ganesh Remedies incorporates wholly owned subsidiary in United States 25 Aug, 9:59 AM Shree Ganesh Remed. - Quaterly Results 31 Jul, 6:20 PM Shree Ganesh Remed. - Quaterly Results 31 Jul, 6:20 PM Shree Ganesh Remed. - Quaterly Results 31 Jul, 6:20 PM Shree Ganesh Remedies gets FDA license to manufacture products at Ankleshwar facility 13 Jul, 1:03 PM Shree Ganesh Remedies informs about analyst meet 20 Jun, 5:06 PM Shree Ganesh Remed. - Quaterly Results 30 May, 10:45 PM Shree Ganesh Remed. - Quaterly Results 30 May, 10:45 PM Shree Ganesh Remedies informs about update 27 Jan, 4:52 PM Shree Ganesh Remed. - Quaterly Results 16 Jan, 5:05 PM Shree Ganesh Remed. - Quaterly Results 16 Jan, 5:05 PM Shree Ganesh Remed. - Quaterly Results 16 Jan, 5:05 PM Shree Ganesh Remedies informs about clarification with regards to financial results 25 Oct, 12:54 PM Shree Ganesh Remedies informs about newspaper advertisement 25 Oct, 12:47 PM Shree Ganesh Remedies informs about outcome of board meeting 25 Oct, 10:56 AM Shree Ganesh Remed. - Quaterly Results 23 Oct, 11:32 AM Shree Ganesh Remed. - Quaterly Results 12 Jul, 3:39 PM Shree Ganesh Remed. - Quaterly Results 12 Jul, 3:39 PM Shree Ganesh Remed. - Quaterly Results 12 Jul, 3:39 PM Shree Ganesh Remed. - Quaterly Results 6 May, 4:13 PM Shree Ganesh Remed. - Quaterly Results 6 May, 4:13 PM Shree Ganesh Remed. - Quaterly Results 6 May, 4:13 PM Shree Ganesh Remedies informs about certificate 19 Apr, 1:09 PM Shree Ganesh Remedies informs about postal ballot 12 Mar, 10:25 AM Shree Ganesh Remedies informs about press release 20 Jan, 10:31 AM Shree Ganesh Remed. - Quaterly Results 18 Jan, 12:36 PM Shree Ganesh Remed. - Quaterly Results 18 Jan, 12:36 PM Shree Ganesh Remed. - Quaterly Results 18 Jan, 12:36 PM Shree Ganesh Remedies informs about allotment of bonus equity shares 3 Nov, 2:14 PM Shree Ganesh Remedies informs about outcome of board meeting 27 Oct, 12:53 PM Shree Ganesh Remedies informs about voting results 23 Oct, 12:32 PM Shree Ganesh Remedies fixes record date for issue of bonus equity shares 16 Oct, 3:12 PM Shree Ganesh Remedies acquires entire stake in Akshar Jyot 8 Sep, 4:56 PM Shree Ganesh Remedies to acquire 74% stake in Dhari Chemicals 8 Sep, 9:52 AM Shree Ganesh Remedies informs about investor presentation 13 Jul, 3:00 PM Shree Ganesh Remedies informs about announcement 27 May, 11:47 AM

Shree Ganesh Remed. Stock Price Analysis and Quick Research Report. Is Shree Ganesh Remed. an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Shree Ganesh Remed. and its performance over the period of time. Shree Ganesh Remed. stock price today is Rs 700.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Shree Ganesh Remed. cash from the operating activity was Rs 30.4482 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Shree Ganesh Remed. has a Debt to Equity ratio of 0.2974 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Shree Ganesh Remed. , the EPS growth was 80.3813 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Shree Ganesh Remed. has OPM of 33.2105064998403 % which is a good sign for profitability.
     
  • ROE: Shree Ganesh Remed. have a healthy ROE of 26.8674 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Shree Ganesh Remed. is Rs 700. One can use valuation calculators of ticker to know if Shree Ganesh Remed. share price is undervalued or overvalued.
Last Updated on:
Brief about Shree Ganesh Remed.
X